van de Loosdrecht AA - Search Results

1

Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.

van de Loosdrecht AA, van den Ancker W, Houtenbos I, Ossenkoppele GJ, Westers TM. van de Loosdrecht AA, et al. Among authors: van den ancker w. Handb Exp Pharmacol. 2009;(188):319-48. doi: 10.1007/978-3-540-71029-5_15. Handb Exp Pharmacol. 2009. PMID: 19031033 Review.

2

Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Langenhuijsen MM. van de Loosdrecht AA, et al. Cancer Immunol Immunother. 1992;34(6):393-8. doi: 10.1007/BF01741750. Cancer Immunol Immunother. 1992. PMID: 1563017 Free PMC article.

3

Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue.

Rebel VI, Ossenkoppele GJ, van de Loosdrecht AA, Wijermans PW, Beelen RH, Langenhuijsen MM. Rebel VI, et al. Among authors: van de loosdrecht aa. Leuk Res. 1992;16(5):443-51. doi: 10.1016/0145-2126(92)90169-8. Leuk Res. 1992. PMID: 1625469

4

Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study.

van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM. van de Loosdrecht AA, et al. J Immunol Methods. 1991 Jul 26;141(1):15-22. doi: 10.1016/0022-1759(91)90205-t. J Immunol Methods. 1991. PMID: 1865120

5

[Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH. van de Loosdrecht AA, et al. Ned Tijdschr Geneeskd. 1989 Oct 7;133(40):1994-5. Ned Tijdschr Geneeskd. 1989. PMID: 2812087 Dutch. No abstract available.

6

Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins.

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Langenhuijsen MM. van de Loosdrecht AA, et al. Cancer Res. 1993 Sep 15;53(18):4399-407. Cancer Res. 1993. PMID: 7689934

7

Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia.

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, van Hooff MH, Dräger AM, Huijgens PC, Langenhuijsen MM. van de Loosdrecht AA, et al. Among authors: van hooff mh. Leukemia. 1994 Aug;8(8):1392-400. Leukemia. 1994. PMID: 8057679

8

A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.

van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM. van de Loosdrecht AA, et al. J Immunol Methods. 1994 Sep 14;174(1-2):311-20. doi: 10.1016/0022-1759(94)90034-5. J Immunol Methods. 1994. PMID: 8083535

9

Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

Kiburg B, van de Loosdrecht AA, Schweitzer KM, Ossenkoppele GJ, Müller LJ, Heimans JJ, Huijgens PC. Kiburg B, et al. Among authors: van de loosdrecht aa. Br J Cancer. 1994 Mar;69(3):497-501. doi: 10.1038/bjc.1994.90. Br J Cancer. 1994. PMID: 8123480 Free PMC article.

10

In vitro purging of clonogenic leukaemic cells from human bone marrow by interferon-gamma-activated monocytes.

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Schweitzer KM, Langenhuijsen MM. van de Loosdrecht AA, et al. Cancer Immunol Immunother. 1994 May;38(5):346-52. doi: 10.1007/BF01525514. Cancer Immunol Immunother. 1994. PMID: 8162617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters